Menstrual Health and Genital Hygiene Status in Cerebral Palsy

Sponsor
Özge Çoban (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04985045
Collaborator
(none)
128
2

Study Details

Study Description

Brief Summary

There is little information about the menstrual health and genital hygiene behaviors of young women with CP. The most important reason for this is that women with CP did not meet the inclusion criteria and were excluded from the study. This may lead to a knowledge gap that limits the design of approaches that can help women and families with CP. Therefore, this study was planned to determine menstrual health and genital hygiene behaviors in women with CP.

Condition or Disease Intervention/Treatment Phase
  • Other: Evaluation

Study Design

Study Type:
Observational
Anticipated Enrollment :
128 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Determination of Menstrual Health and Genital Hygiene Status in Women With Cerebral Palsy
Anticipated Study Start Date :
Aug 1, 2021
Anticipated Primary Completion Date :
Aug 30, 2021
Anticipated Study Completion Date :
Sep 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Control group

Healthy women will be included

Other: Evaluation
Individuals' menstrual status, pain, menstrual symptoms and genital hygiene behaviors will be evaluated.

Cerebral palsy group

Women with cerebral palsy will be included

Other: Evaluation
Individuals' menstrual status, pain, menstrual symptoms and genital hygiene behaviors will be evaluated.

Outcome Measures

Primary Outcome Measures

  1. Menstrual Pain [A month]

    The highest pain intensity experienced by individuals during the menstrual period will be determined using the visual analog scale. Individuals will be asked to determine the highest pain intensity experienced during menstruation on a straight line from 0 to 10 cm. In this chart, "0" means I have no pain, "10" means I have unbearable pain. Facial expressions will be added below the line to increase the clarity of the assessment. At the same time, adolescents will be asked to mark where the pain is on the front and back body images.

  2. Menstruation-related symptoms [A month]

    Menstruation-related symptoms of individuals will be determined using the "Menstruation Symptom Scale (MSS)". The Menstruation Symptom Scale was developed by Chesney and Tasto in 1975 to assess menstrual pain and symptoms. It is a widely used scale in studies conducted in many different countries. The scale consists of 22 items questioning the symptoms related to menstruation and is scored in a five-point Likert type as never (1), rarely (2), sometimes (3) often (4) and always (5). The total score of MSS is calculated by taking the mean score of all items in the scale. An increase in the total score indicates an increase in the severity of menstrual symptoms. The scale has three sub-dimensions: 'Negative Effects/Somatic Complaints', 'Menstrual Pain' and 'Coping Methods'.

  3. Genital Hygiene status [A month]

    The genital hygiene behaviors of individuals will be evaluated using the "Genital Hygiene Behaviors Scale (GHDS)". The GHQ scale is a five-point Likert-type scale consisting of 23 items and 3 sub-dimensions developed by Karahan (2017). The level of agreement with the statements is scored as "Totally agree (5)", Agree (4), Undecided (3) Disagree (2), Completely disagree (1). The total score is obtained by adding the point values of the answers given to all the statements. The first 12 items of the scale include general hygiene habits, 13-20. substances, menstrual hygiene, 21-23. items are intended to determine abnormal finding awareness. 5 items of the scale have reverse entries. The total score varies between 23-115. Higher scores indicate improved genital hygiene.

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 30 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

for women with cerebral palsy (CP)

  1. Participating in the research voluntarily,

  2. Being diagnosed with CP

  3. To be GMFCS level I-II-II

  4. to be 10-30 years old,

  5. Being able to read and write Turkish,

  6. Not having any mental problems that prevent cooperation and understanding,

  7. Being a woman

  8. To have menstruated at least once.

For healthy women

  1. Participating in the research voluntarily,

  2. to be 10-30 years old,

  3. Being able to read and write Turkish,

  4. Not having any mental problems that prevent cooperation and understanding,

  5. Being a woman

  6. To have menstruated at least once.

Exclusion Criteria:
  1. Having a history of pregnancy

  2. Having an acute genital infection

  3. To have undergone gynecological surgery.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Özge Çoban

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Özge Çoban, Universith of Health Science, Health Science Faculty, Lecturer, Gulhane School of Medicine
ClinicalTrials.gov Identifier:
NCT04985045
Other Study ID Numbers:
  • 2021/191
First Posted:
Aug 2, 2021
Last Update Posted:
Aug 2, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 2, 2021